Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2010 Publisher: Alliance Pharmaceuticals Ltd, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, UK
Edrophonium Injection BP 10mg/1ml.
| Pharmaceutical Form |
|---|
|
Ampoules. |
Each ampoule contains 10mg Edrophonium Chloride BP in 1ml of solution.
| Active Ingredient | Description | |
|---|---|---|
| Edrophonium |
Edrophonium is a reversible acetylcholinesterase inhibitor with rapid onset and short duration of action resulting in an increase of acetylcholine in the neuromuscular junction (NMJ). For many years, edrophonium was FDA-approved to be utilized to diagnose MG. |
| List of Excipients |
|---|
|
Sodium sulphite anhydrous |
Colourless glass ampoules coded with orange and emerald green colour rings, each containing 1ml of solution, in packs of 10 ampoules.
The ampoule solution is almost colourless.
Alliance Pharmaceuticals Ltd, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, UK
PL 16853/0118
24 April 1992
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
